Home | freeCME.com

Clinical Briefings™: Treating Glaucoma with Rho Kinase Inhibition: Analyzing the Mechanism of Action and Latest Clinical Data
Glaucoma is a heterogeneous group of diseases that has become a major cause of irreversible blindness worldwide.
CME: 1.0
Test Your Skills: Diagnosis and Treatment Challenges in a Cardiopulmonary Patient
In this case-based activity, Dr. Harrison Farber takes learners through the differential diagnosis and treatment of two cardiopulmonary patients. Discussion topics include differential diagnostic procedures, guideline recommendations, and therapy selection.
CME: 0.75
Insights & Updates in the Multidisciplinary Treatment of Metastatic Melanoma
To inform physicians on strategies for selecting adjuvant therapy in melanoma as well as use of systemic therapy in metastatic melanoma based on new treatment approvals of clinical interest, with practice-changing implications.
CME: 0.5
Spinal Muscular Atrophy: Best Practices in Diagnosis and Management
Upon completion of this activity, participants should be able to Summarize clinical practice/consensus guidelines for the comprehensive management of spinal muscular atrophy (SMA)
CME: 1.0
Community Practice Connection™ “Cases and Conversations: Patient-Minded Approaches to Managing Fabry Disease.”
Fabry disease is a rare, X-linked lysosomal storage disorder that results in deficient or absent α-galactosidase and lysosomal accumulation of globotriaosylceramide and related glycosphingolipids across a wide variety of cells and tissues.
CME: 1.0
Targeting of PCSK9 with siRNA for LDL-C Reduction in a High-Risk Population
Explain the role of non-statin therapies in cardiovascular risk management. Summarize the mechanism of action, efficacy, and safety of novel agents for LDL-C and ASCVD risk reduction
CME: 1.25
Clinical Briefings™: Assessing and Managing Ocular Health in Glaucoma
Characterize current intraocular agents used to treat glaucoma according to efficacy, safety, and preservative content
CME: 1.0
Ensuring Optimal Integration of the GLP-1 Receptor Agonists: Review of the Latest Advances and Current Gaps in Care
Evaluate the latest safety and efficacy data for each approved GLP-1 RA Incorporate GLP-1 RAs into effective T2DM treatment plans based on the latest expert and guideline recommendations.
CME: 1.0

freeCME.com has provided the broadest range of free continuing education available for more than a decade.

Healthcare professionals come to us knowing they will find activities that consistently meet their continuing education requirements:

Clinical Briefings™: Treating Glaucoma with Rho Kinase Inhibition: Analyzing the Mechanism of Action and Latest Clinical Data

Test Your Skills: Diagnosis and Treatment Challenges in a Cardiopulmonary Patient

Insights & Updates in the Multidisciplinary Treatment of Metastatic Melanoma

Spinal Muscular Atrophy: Best Practices in Diagnosis and Management

Community Practice Connection™ “Cases and Conversations: Patient-Minded Approaches to Managing Fabry Disease.”

Targeting of PCSK9 with siRNA for LDL-C Reduction in a High-Risk Population

Clinical Briefings™: Assessing and Managing Ocular Health in Glaucoma

Ensuring Optimal Integration of the GLP-1 Receptor Agonists: Review of the Latest Advances and Current Gaps in Care